Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2000-08-04
2002-04-09
Higel, Floyd D. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S314000, C514S374000, C514S422000, C514S423000, C514S395000, C514S445000, C546S166000, C546S251000, C548S235000, C548S453000, C548S579000, C548S491000, C549S496000, C558S392000, C564S086000
Reexamination Certificate
active
06369069
ABSTRACT:
The invention relates to compounds of the formula (I),
in which the symbols have the following meaning:
R(1) is
1. alkyl having 1, 2, 3, 4, 5, 6, 7 or 8 carbon atoms;
2. alkyl having 1, 2, 3, 4, 5, 6, 7 or 8 carbon atoms, in which one to all hydrogen atoms are replaced by fluorine;
3. alkenyl having 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 or 12 carbon atoms; or
4. —C
n
H
2n−nn
—Y,
nn is zero or 2; and
n is zero, 1, 2, 3 or 4; where n is unequal to zero or 1 if nn is equal to 2;
5. —C
n
H
2n−nn
—Y,
nn is zero or 2; and
n is 1, 2, 3 or 4; where n is unequal to 1 if nn is equal to 2;
where 1, 2 or 3 hydrogen atoms in the divalent radical —C
n
H
2n−nn
— independently of one another are replaced by a radical from the group consisting of
1. aryl having 6, 7, 8, 9, 10, 11, 12, 13 or 14 carbon atoms, preferably phenyl, 1-naphthyl or 2-naphthyl;
2. amino;
3. N(R(22)R(23);
4. alkoxycarbonyl;
5. COOR(16);
6. alkyl having 1, 2, 3 or 4 carbon atoms;
7. (C
6
-C
14
)-aryl-(C
1
-C
4
)-alkylcarbonyl, preferably phenylacetyl;
R(2) is
1. hydrogen;
2. alkyl having 1, 2, 3, 4, 5, 6, 7 or 8 carbon atoms;
3. alkyl having 1, 2, 3, 4, 5, 6, 7 or 8 carbon atoms, in which one to all hydrogen atoms are replaced by fluorine;
4. alkenyl having 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 or 12 carbon atoms;
5. alkynyl having 2, 3, 4, 5, 6, 7 or 8 carbon atoms;
6. —C
n
H
2n−nn
—Z,
nn is zero or 2; and
n is zero, 1, 2, 3 or 4; where n is unequal to zero or 1 if nn is equal to 2;
7. —C
n
H
2n−nn
—Z,
nn is zero or 2; and
n is 1, 2, 3 or 4, where n is unequal to 1 if nn is equal to 2;
where 1, 2 or 3 hydrogen atoms in the divalent radical —C
n
H
2n−nn
— independently of one another are replaced by a radical from the group consisting of
1. aryl having 6, 7, 8, 9, 10, 11, 12, 13 or 14 carbon atoms, preferably phenyl, 1-naphthyl or 2-naphthyl;
2. amino;
3. N(R(22)R(23);
4. (C
1
-C
4
)-alkoxycarbonyl;
5. COOR(16);
6. alkyl having 1, 2, 3 or 4 carbon atoms;
R(3) and R(4) independently of one another are hydrogen or alkyl having 1, 2, 3, 4, 5, 6, 7 or 8 carbon atoms;
R(5), R(6) and R(7) independently of one another are hydrogen, alkyl having 1, 2, 3, 4, 5, 6, 7 or 8 carbon atoms, F, Cl, Br, I, CF
3
, —CN, —NO
2
, SO
q
—R(8), CO—R(21) or O—R(10);
R(8) is alkyl having 1, 2, 3, 4, 5, 6, 7 or 8 carbon atoms, NR(11)R(12) or phenyl which is unsubstituted or is substituted by 1, 2 or 3 identical or different radicals from the group consisting of F, Cl, Br, I, CF
3
, methyl, methoxy, hydroxyl or NR(11)R(12);
R(9) and R(21) independently of one another are hydrogen, alkyl having 1, 2, 3, 4, 5, 6, 7 or 8 carbon atoms or OR(13);
R(10) is hydrogen, alkyl having 1, 2, 3, 4, 5, 6, 7 or 8 carbon atoms optionally substituted by (C
1
-C
4
)-alkoxy; or phenyl which is unsubstituted or is substituted by 1, 2 or 3 identical or different radicals from the group consisting of F, Cl, Br, I, CF
3
, methyl, methoxy, hydroxyl or NR(11)R(12);
R(11), R(12), R(19) and R(20) independently of one another are hydrogen, alkyl having 1, 2, 3 or 4 carbon atoms or (C
1
-C
4
)-alkanoyl, preferably acetyl;
R(13) is hydrogen or alkyl having 1, 2, 3, 4, 5, 6, 7 or 8 carbon atoms;
X is carbonyl, —CO—NH—, —CO—CO— or sulfonyl;
Y and Z independently of one another are
1. aryl having 6, 7, 8, 9, 10, 11, 12, 13 or 14 carbon atoms, preferably phenyl, 1-naphthyl or 2-naphthyl;
2. a radical as defined in 1., which is substituted by 1, 2, 3, 4 or 5 identical or different radicals from the group consisting of alkyl having 1, 2, 3, 4, 5, 6, 7 or 8 carbon atoms, aryl having 6, 7, 8, 9, 10, 11, 12, 13 or 14 carbon atoms, preferably phenyl, 1-naphthyl or 2-naphthyl, F, Cl, Br, I, CF
3
, SO
q
R(18), OR(16), NR(19)R(20), —CN, NO
2
or CO—R(9); or where two radicals together form a fused heterocyclyl radical, preferably methylenedioxy.
3. heteroaryl having 1, 2, 3, 4, 5, 6, 7, 8 or 9 carbon atoms;
4. a radical as defined in 3., which is substituted by 1, 2 or 3 identical or different radicals from the group consisting of F, Cl, Br, I, CF
3
, CH
3
, methoxy, hydroxyl or NR(11)R(12);
5. cycloalkyl having 3, 4, 5, 6, 7, 8, 9 or 10 carbon atoms, preferably cyclopropyl, cyclopentyl, cyclohexyl. 1,2,3,4-tetrahydronaphthyl or indanyl;
6. a radical as defined in 5, substituted by aryl having 6, 7, 8, 9, 10, 11, 12, 13 or 14 carbon atoms, preferably phenyl, 1-naphthyl or 2-naphthyl;
7. O—R(14);
8. O—R(17);
9. —SO
2
—R(14);
10. arylalkylcarbonyl, preferably phenyl-CH
2
—CO—; or
11. heterocyclyl;
R(14) and R(17) independently of one another are
1. hydrogen;
2. alkyl having 1, 2, 3, 4, 5, 6, 7 or 8 carbon atoms;
3. alkenyl having 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 or 12 carbon atoms;
4. —C
n
H
2n−nn
-phenyl,
nn is zero or 2; and
n is zero, 1, 2, 3 or 4; where n is unequal to zero or 1 if nn is equal to 2;
5. a radical as defined in 4., where the phenyl moiety is substituted by 1, 2 or 3 identical or different radicals from the group consisting of alkyl having 1, 2, 3, 4, 5, 6, 7 or 8 carbon atoms, F, Cl, Br, I, CF
3
, SO
q
R(15), OR(16), NR(11)R(12), —CN, —NO
2
or CO—R(9); or
R(15) and R(18) independently of one another are alkyl having 1, 2, 3 or 4 carbon atoms, alkyl having 1, 2, 3 or 4 carbon atoms, in which one to all hydrogen atoms are replaced by fluorine, preferably CF
3
, or NR(11)R(12);
R(16) is
1. hydrogen,
2. alkyl having 1, 2, 3 or 4 carbon atoms,
3. alkyl having 1, 2, 3 or 4 carbon atoms, substituted by (C
1
-C
4
)-alkoxy,
4. alkyl having 1, 2, 3 or 4 carbon atoms, in which one to all hydrogen atoms are replaced by fluorine, preferably CF
3
;
5. aryl having 6, 7, 8, 9, 10, 11, 12, 13 or 14 carbon atoms, preferably phenyl, 1-naphthyl or 2-naphthyl;
6. a radical as defined in 5., which is substituted by 1, 2 or 3 identical or different radicals from the group consisting of F, Cl, Br, I, CF
3
, NR(19)R(20), —CN, NO
2
;
R(22) and R(23) independently of one another are hydrogen or CO—OR(24);
R(24) is hydrogen, alkyl having 1, 2, 3, 4, 5, 6, 7 or 8 carbon atoms or —C
n
H
2n
-phenyl where n is equal to 1, 2, 3 or 4;
q independently of one another is zero, 1 or 2;
and their physiologically tolerable salts.
Preferred compounds of the formula (I) are those where
R(1) is
1. alkyl having 1, 2, 3, 4 or 5 carbon atoms;
2. alkyl having 1, 2, 3, 4 or 5 carbon atoms, in which one to all hydrogen atoms are replaced by fluorine;
3. alkenyl having 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 or 12 carbon atoms; or
4. —C
n
H
2n−nn
—Y,
nn is zero or 2; and
n is zero, 1, 2, 3 or 4; where n is unequal to zero or 1 if nn is equal to 2;
5. —C
n
H
2n−nn
—Y,
nn is zero or 2; and
n is 1, 2, 3 or 4; where n is unequal to 1 if nn is equal to 2;
where 1, 2 or 3 hydrogen atoms in the divalent radical —C
n
H
2n−nn
— independently of one another are replaced by a radical from the group consisting of
1. aryl having 6, 7, 8, 9, 10, 11, 12, 13 or 14 carbon atoms, preferably phenyl, 1-naphthyl or 2-naphthyl;
2. amino;
3. NR(22)R(23);
4. alkoxycarbonyl;
5. COOR(16);
6. alkyl having 1, 2, 3 or 4 carbon atoms;
7. (C
6
-C
14
)-aryl-(C
1
-C
4
)-alkylcarbonyl, preferably phenyl-acetyl;
R(2)is
1. hydrogen;
2. alkyl having 1, 2, 3, 4, 5 or 5 carbon atoms;
3. alkyl having 1, 2, 3, 4, or 5 carbon atoms, in which one to all hydrogen atoms are replaced by fluorine;
4. alkenyl having 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 or 12 carbon atoms;
5. alkynyl having 2, 3, 4, or 5 carbon atoms;
6. —C
n
H
2n−nn
—Z,
nn is zero or 2; and
n is zero, 1, 2, 3 or 4; where n is unequal to zero or 1 if nn is equal to 2;
7. —C
n
H
2n−nn
—Z,
nn is zero or 2; and
n is 1, 2, 3 or 4, where n is unequal to 1 if nn is equal to 2;
where 1, 2 or 3 hydrogen atoms in the divalent radical —C
n
H
2n−nn
— independently of one another are replaced by a radical from the group consisting of
1. aryl having 6, 7, 8, 9, 10, 11, 12, 13 or 14 carbon atoms, preferably phenyl, 1-naphthyl or 2-naphthyl;
2. amino;
3. N(R(22)R(23);
4. (C
1
-C
4
)-alkoxycarbonyl;
5. COOR(16);
6. alkyl having 1, 2, 3 or 4 carbon atoms;
R(3) and R(4) independently of one another are hydrogen or alkyl having 1, 2, 3 or 4 carbon atoms;
R(5), R(6) and R(7) i
Faber Sabine
Jansen Hans-Willi
Kleemann Heinz-Werner
Lang Hans-Jochen
Petry Stefan
Aventis Pharma Deutschland GmbH
Finnegan Henderson Farabow Garrett & Dunner LLP
Higel Floyd D.
Sackey Ebenezer
LandOfFree
Biphenylsulfonyl cyanamides, method for the production... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Biphenylsulfonyl cyanamides, method for the production..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biphenylsulfonyl cyanamides, method for the production... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2849824